506. Acquired Osteomalacia Associated with Autoantibodies against PHEX.
作者: Yoshitomo Hoshino.;Kazuo Okamoto.;Tomohiro Ogawa.;Hajime Kato.;Koki Irie.;So Watanabe.;Soichiro Kimura.;Naoko Hidaka.;Yuka Kinoshita.;Hiroshi Kobayashi.;Daisuke Hagiwara.;Masakazu Kogawa.;Hiroshi Takayanagi.;Sakae Tanaka.;Masaomi Nangaku.;Noriko Makita.;Peter D Burbelo.;Taku Saito.;Nobuaki Ito.
来源: N Engl J Med. 2025年392卷5期513-515页 512. Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.
作者: Lorenzo Guglielmetti.;Uzma Khan.;Gustavo E Velásquez.;Maelenn Gouillou.;Amanzhan Abubakirov.;Elisabeth Baudin.;Elmira Berikova.;Catherine Berry.;Maryline Bonnet.;Matteo Cellamare.;Vijay Chavan.;Vivian Cox.;Zhanna Dakenova.;Bouke Catherine de Jong.;Gabriella Ferlazzo.;Aydarkhan Karabayev.;Ohanna Kirakosyan.;Nana Kiria.;Mikanda Kunda.;Nathalie Lachenal.;Leonid Lecca.;Helen McIlleron.;Ilaria Motta.;Sergio Mucching Toscano.;Hebah Mushtaque.;Payam Nahid.;Lawrence Oyewusi.;Samiran Panda.;Sandip Patil.;Patrick P J Phillips.;Jimena Ruiz.;Naseem Salahuddin.;Epifanio Sanchez Garavito.;Kwonjune J Seung.;Eduardo Ticona.;Lorenzo Trippa.;Dante E Vargas Vasquez.;Sean Wasserman.;Michael L Rich.;Francis Varaine.;Carole D Mitnick.; .
来源: N Engl J Med. 2025年392卷5期468-482页
For decades, poor treatment options and low-quality evidence plagued care for patients with rifampin-resistant tuberculosis. The advent of new drugs to treat tuberculosis and enhanced funding now permit randomized, controlled trials of shortened-duration, all-oral treatments for rifampin-resistant tuberculosis.
|